Sensorion SA (EPA:ALSEN)
France · Delayed Price · Currency is EUR 0.6600
-0.0400 (-5.71%)
At close: Mar 13, 2026
Sensorion Market Cap
Sensorion has a market cap or net worth of €198.23 million as of March 13, 2026. Its market cap has increased by 14.18% in one year.
Market Cap
198.23M
Enterprise Value
142.71M
Revenue
5.65M
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.66
Market Cap Chart
Since April 21, 2015, Sensorion's market cap has increased from 20.46M to 198.23M, an increase of 869.03%. That is a compound annual growth rate of 23.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 13, 2026 | 198.23M | 95.77% |
| Dec 31, 2025 | 101.25M | -47.00% |
| Dec 31, 2024 | 191.03M | 137.65% |
| Dec 29, 2023 | 80.38M | 171.97% |
| Dec 30, 2022 | 29.56M | -80.74% |
| Dec 31, 2021 | 153.45M | 33.34% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Valneva SE | 783.28M |
| MedinCell | 746.81M |
| Genfit | 433.47M |
| Cellectis | 230.72M |
| Transgene | 213.59M |
| MaaT Pharma | 128.33M |
| Innate Pharma | 119.22M |
| Adocia | 118.93M |